PYGO2 and pancreatic neoplasm: For example, PVT1 were found to be upregulated in pancreatic cancer and overcome gemcitabine resistance through sponging miR-619- 5p, leading to upregulation of Pygo2, which is a downstream target of miR-619-5p [39].